The Medtronic HVAD Recall: What Patients and Families Need to Know

The HeartWare HVAD is a ventricular assist device, a mechanical pump surgeons implant in patients with advanced heart failure to help a weakened heart move blood through the body. Cardiologists use it two ways: as a bridge to keep a patient alive until a heart transplant, and as long-term "destination" therapy for patients who will never receive a new heart. Either way, the patient's life depends on the pump running.

Medtronic acquired HeartWare in 2016 for $1.1 billion. By then, the device already had a troubled safety record. The trouble did not stop.

The HVAD System was the subject of repeated Class I recalls, the FDA's most serious category, reserved for defects the agency believes could cause serious injury or death. The FDA maintains a dedicated page just to track the recalls related to this one device. A short timeline of the major actions:

2015 to 2017: Medtronic issued safety notices about connector wear and damaged pins in HVAD controllers and power adapters; the FDA classified a worldwide field action on those components as Class I in 2017.

2018: a Class I recall over oxidation at the connection between the power source and the controller. That oxidation could cause an unintended pump stop, a life-threatening event for a patient whose circulation depends on the device.

March 2021: a Class I recall for failed or delayed pump restarts, which the FDA linked to 29 complaints, including 19 serious injuries and two deaths. A pump that stops and does not promptly restart can cause a stroke or death within minutes.

April 2021: a Class I recall covering roughly 106,000 HVAD controllers, adapters, cables, monitors, and batteries, tied by the FDA to eight injuries and 12 deaths.

May 2021: a third Class I recall that year covered carrying cases, driveline coverings, and controller power-up instructions; the FDA linked it to 64 injuries and one death.

2022: after the market withdrawal, Medtronic recalled HVAD batteries following a patient death in which two batteries failed at the same time. The company reported more than 1,100 complaints tied to the electrical fault. A separate weld defect in the pump itself drew another Class I recall the same year.

By the time Medtronic stopped all sales in June 2021, roughly 4,000 U.S. patients had the device implanted. Thousands still carry it.

Medtronic did not withdraw the HVAD as a routine business decision. The FDA's announcement of the June 2021 stop was explicit: the HVAD showed a higher frequency of neurological adverse events and mortality compared with the competing device on the market, on top of the pump-restart defect. Faced with a safer alternative available to patients and a mounting recall history, Medtronic stopped selling and distributing the device rather than continue to defend it.

A congressional inquiry followed. In 2021, a member of Congress wrote to the FDA to criticize the agency's oversight of the device across multiple recall cycles. The letter argued the FDA had failed to protect the thousands of Americans who still had the pump implanted. When a federal lawmaker says that about a device still inside patients, families are entitled to take the device's history seriously.

A recall does not compensate anyone. It is a manufacturer's acknowledgment, sometimes reluctant, that its product carries a risk the company already knew about. The legal claim comes after, when a patient or family can show the device failed and caused harm that would not have happened otherwise.

The failure patterns families should look for in the medical history:

A pump stoppage or unexpected shutdown, even a brief one, followed by a stroke, cardiac event, or death. A battery failure in which both power sources failed near the same time and left the patient without warning. A driveline or connector failure tied to wear, corrosion, or a damaged port. And a revision surgery or pump exchange that itself carried complications; Medtronic's own guidance acknowledged that exchange procedures carry real risk, which is part of why so many patients still carry the withdrawn device.

If one of those patterns appears in your family's history, even years ago, the connection between the device and the harm may never have been explained to you at the time. That is common. It is also exactly what a case review is for.

Cases against device manufacturers rest on product liability theories: design defect, manufacturing defect, and failure to warn. These are different from a malpractice claim against a doctor or hospital, though the two can overlap in an HVAD case. A cardiologist who failed to counsel a patient about a known recall, or a hospital that failed to act on a recall notice for a device its patient depended on, may carry independent liability alongside the manufacturer.

One more path matters for veterans' families: if the implant or the follow-up care happened at a VA medical center, claims about the medical care proceed under the Federal Tort Claims Act, with its own two-year administrative deadline, while the product claims against Medtronic proceed separately. The two tracks can run in parallel; see our FTCA article for how those cases work.

There is no multidistrict litigation consolidating HVAD cases. Each case proceeds on its own facts, before its own judge, on its own timeline. That cuts both ways: there is no waiting on a distant consolidated docket, but the quality of the individual record (the medical records, the device data, the timeline of symptoms) matters more, not less.

For families in our region, the statutes of limitations are unforgiving. Virginia generally allows two years from the date of injury or death for personal injury, wrongful death, and product liability claims. D.C. allows three years, and Maryland three years with an outer cap. The discovery rule can affect when the clock starts if the connection between the device and the harm was not reasonably apparent at the time, which in HVAD cases it often was not. Whether the rule saves a particular claim is a case-specific question that should be answered by an attorney, not assumed in either direction.

The practical advice is simple: if you suspect the device, do not wait to find out where you stand. The review costs nothing, and the deadline analysis is usually the first thing we do.

National Malpractice Lawyers represents patients and families in claims involving defective medical devices and the medical negligence that can accompany their use. In these cases the story usually lives in three places at once: the medical records, the device history, and the recall timeline. We review them together.

If you or a family member had an HVAD implanted and experienced a pump failure, battery failure, stroke, or death that may be connected to the device, contact us for a confidential case review. Peter Anderson reads these inquiries personally. There is no fee unless we recover for you.